US 12,112,842 B2
System and method for improving the drug therapy management
Stavroula Mougiakakou, Bern (CH); Qingnan Sun, Bern (CH); Marko Jankovic, Bern (CH); Laurent-Dominique Piveteau, Lausanne (CH); Stephan Proennecke, Lausanne (CH); and João Budzinski, Lausanne (CH)
Assigned to UNIVERSITAT BERN, Bern (CH); and DEBIOTECH S.A., Lausanne (CH)
Filed by UNIVERSITÄT BERN, Bern (CH); and DEBIOTECH S.A., Lausanne (CH)
Filed on Feb. 14, 2022, as Appl. No. 17/670,967.
Application 17/670,967 is a continuation of application No. 16/494,753, granted, now 11,430,557, previously published as PCT/IB2018/051769, filed on Mar. 16, 2018.
Claims priority of application No. PCT/IB2017/051571 (WO), filed on Mar. 17, 2017.
Prior Publication US 2022/0254473 A1, Aug. 11, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. G16H 20/17 (2018.01); A61M 5/142 (2006.01); A61M 5/168 (2006.01); A61M 5/172 (2006.01); G16H 40/63 (2018.01)
CPC G16H 20/17 (2018.01) [A61M 5/14216 (2013.01); A61M 5/14248 (2013.01); A61M 5/16831 (2013.01); A61M 5/1723 (2013.01); G16H 40/63 (2018.01); A61M 2005/14268 (2013.01); A61M 2005/16868 (2013.01); A61M 2202/07 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3592 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2205/8206 (2013.01); A61M 2230/201 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A system for diabetes management of a patient, the system configured to provide a daily therapy to the patient, the system comprising:
an input device configured to receive glucose data relating to a glucose level of the patient;
a delivery device configured to deliver insulin to the patient according to a medication delivery parameter, the medication delivery parameter including a basal rate or a bolus;
a memory device configured to store
glucose data, and
the medication delivery parameter or a Carbohydrate to Insulin Ratio (CIR) information of the patient; and
a tuning module including a data processor, the data processor configured to
retrieve, from the memory device, glucose data comprising at least two glucose measurements performed over a day by a self-monitoring blood glucose device;
retrieve, from the memory device, the medication delivery parameter executed by the delivery device over the day or the CIR, and
determine, based on the retrieved data, a therapy modification including a modification of the basal rate or the CIR,
wherein the therapy modification is intended to the patient for a subsequent time period.